Tumimpad, Raiza Mae B.

HRN: 12-66-04  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/13/2025
CEFTRIAXONE 1G (VIAL)
05/13/2025
05/19/2025
IV DRIP
2grams
OD
Acute Tonsillopharyngitis
Waiting Final Action 
05/13/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
05/13/2025
05/19/2025
IVT
1.5g
Q6
Acute Tonsillopharyngitis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: